Evaluation of Anterior Quadratus Lumborum Block for Postoperative Analgesia in Hip Arthroscopy
1 other identifier
interventional
96
1 country
1
Brief Summary
Hip arthroscopy is performed frequently and the postoperative course often involves moderate to severe pain. There remains no definitive perioperative pain regimen that has been proven to be effective and safe for this ambulatory procedure. Some institutions perform peripheral nerve blocks either preoperatively or postoperatively as a rescue block. All of these PNBs lead to quadriceps weakness which may impede earlier mobilization and physical therapy. While some case reports exist, there have not been any studies evaluating the QLB for hip arthroscopy patients. As previously mentioned, the technique is easy to perform, well-tolerated by patients, and avoids side effects such as hypotension, urinary retention, or the quadriceps weakness associated with lumbar plexus blockade.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Jun 2018
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2018
CompletedFirst Posted
Study publicly available on registry
February 14, 2018
CompletedStudy Start
First participant enrolled
June 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 9, 2021
CompletedResults Posted
Study results publicly available
August 19, 2022
CompletedAugust 19, 2022
July 1, 2022
2.6 years
January 25, 2018
April 8, 2022
July 26, 2022
Conditions
Outcome Measures
Primary Outcomes (5)
Numerical Pain Rating System (NRS) Pain Scores
Pain scores at rest and with movement will be through 24 hours after surgery. Score scale is from 0-10. 0 means no pain, 10 means worst pain. A lower score is a better outcome.
30min after Post Anesthesia Care Unite (PACU) arrival
Numerical Pain Rating System (NRS) Pain Scores
Pain scores at rest and with movement will be through 24 hours after surgery. Score scale is from 0-10. 0 means no pain, 10 means worst pain. A lower score is a better outcome.
1 hour after Post Anesthesia Care Unite (PACU) arrival
Numerical Pain Rating System (NRS) Pain Scores
Pain scores at rest and with movement will be through 24 hours after surgery. Score scale is from 0-10. 0 means no pain, 10 means worst pain. A lower score is a better outcome.
2 hours after Post Anesthesia Care Unite (PACU) arrival
Numerical Pain Rating System (NRS) Pain Scores
Pain scores at rest and with movement will be through 24 hours after surgery. Score scale is from 0-10. 0 means no pain, 10 means worst pain. A lower score is a better outcome.
3 hours after Post Anesthesia Care Unite (PACU) arrival
Numerical Pain Rating System (NRS) Pain Scores
Pain scores at rest and with movement will be through 24 hours after surgery. Score scale is from 0-10. 0 means no pain, 10 means worst pain. A lower score is a better outcome.
24 hours after Post Anesthesia Care Unite (PACU) arrival
Secondary Outcomes (10)
Opioid Use
After Surgery to Post Operative Day 1
Number of Patients With Presence of IAFE (Intraabdominal Fluid Extravasation) Following Surgery
Immediately post-op in OR
Number of Patients With Nausea/Vomiting
Up to Post Op Day 1
Antiemetic Use
Up to Post Op Day 1
Number of Participants With Hospital Admission
Up to Post Op Day 1
- +5 more secondary outcomes
Study Arms (2)
QLB Block + Standard of Care
EXPERIMENTALPatients will receive either a spinal (4cc Mepivacaine) or combined spinal epidural anesthetic (dose up 50 5 cc 2% lidocaine) with IV sedation. Intraoperative anti-emetics will consist of IV ondansetron and IV dexamethasone. Intra-operative analgesics will be IV fentanyl, IV acetaminophen, IV ketorolac, and IV ketamine. No Block will be given. Patients will receive a single shot anterior QLB (30cc 0.5% Bupivacaine with 2mg preservative free dexamethasone).
Standard of Care
NO INTERVENTIONPatients will receive either a spinal (4cc Mepivacaine) or combined spinal epidural anesthetic (dose up 50 5 cc 2% lidocaine) with IV sedation. Intraoperative anti-emetics will consist of IV ondansetron and IV dexamethasone. Intra-operative analgesics will be IV fentanyl, IV acetaminophen, IV ketorolac, and IV ketamine. No Block will be given.
Interventions
Anesthetic that will help treat pain and sensation after hip arthroscopy
Ultrasound will help guide the anesthesiologist in performing the nerve block
Eligibility Criteria
You may qualify if:
- Patients scheduled for hip arthroscopy
- Ability to follow study protocol
- English Speaking
You may not qualify if:
- Hepatic or renal insufficiency
- Younger than 18 years old and older than 80
- Allergy or intolerance to one of the study medications
- Chronic gabapentin/pregabalin use (regular use for longer than 3 months)
- Chronic opioid use (daily opioids use for longer than 3 months)
- Patients contraindicated to undergo a spinal anesthetic
- Non English Speakers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital of Special Surgery
New York, New York, 10021, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Stephen Haskins
- Organization
- Hospital for Special Surgery, Anesthesiology
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen Haskins, MD
Hospital for Special Surgery, New York
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2018
First Posted
February 14, 2018
Study Start
June 1, 2018
Primary Completion
December 20, 2020
Study Completion
September 9, 2021
Last Updated
August 19, 2022
Results First Posted
August 19, 2022
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share